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ABSTRACT
Introduction: The purpose of this research was to study the biofilm-forming properties of clinical strains of A.bau-
mannii, isolated from burn wounds in patients of ICU, and their sensitivity to antiseptics. Methods: 220 clinical 
strains of A. baumannii isolated from intensive care unit infected burn patients were the object of the study.  Antisep-
tic sensitivity of Acinetobacter spp. (decamethoxine, chlorhexidine, miramistin, povidone iodine) was investigated 
using double serial dilutions according to the standard procedure. The study of biofilm-forming properties of clinical 
Acinetobacter isolates was performed using the spectrophotometric technique by G.D. Christensen. In order to de-
termine the relationship between the antiseptic sensitivity and biofilm-forming properties of A. baumannii strains, 
we determined the correlation coefficient (r-Pearson), the absolute value of which characterised the binding force. 
Results: Among 435 burn persons, who were involved in the investigated group, representatives of Acinetobacter 
spp. were found in 220 (50.6%), that has revealed the etiological significance of the opportunistic pathogens of 
Acinetobacter isolates in the development of infectious complications of burns in intensive care units. Clinical strains 
of A. baumannii have shown variable susceptible to decamethoxine, chlorhexidine, miramistin, povidone iodine 
and have been found to possess high biofilm-forming properties. The r-Pearson coefficient between sensitivity of A. 
baumannii to investigated antiseptics and biofilm-formation pointed out positive moderate and strong correlations.
Conclusion: Biofilm-formation of Acinetobacter spp. is correlated with their susceptibility to chlorhexidine and povi-
done iodine strongly. However, as a more powerful antimicrobial activity of antiseptic against A. baumannii was as 
weaker correlation had been established.
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INTRODUCTION
According to the data of World Health Organization 
(WHO) surgical site infection (SSI) is the most frequent 
type of health care associated infections worldwide 
and affects up to one third of patients who have 
undergone a surgical procedure (1). The last decade 
marked the emergence of new data on the role of 
opportunistic microorganisms, that can form biofilms, 
in the development of various nosological forms of 
purulent-inflammatory diseases with severe course 
during a treatment in the hospital (2). The spectrum of 
microorganisms causing SSI varies depending on type 
of clinic and unit, where patient undergoes medical 
care and type of surgery. However, Staphylococcus 
spp. (29.4%), Enterobacteriaceae spp. (34.1%), gram-
negative non-fermentative bacilli (6.7%) are known to 
be prominent nosocomial pathogens in intensive care 
unit (ICU) patients including burn and trauma patients 
and those requiring mechanical ventilation (3, 4). 
Nowadays the worldwide emergence of multi-drug 
resistant bacteria has been contributing to substantial 
challenges in treatment and caring for patients. Infections 
caused by them are sometimes life-threatening, 
especially in ICU patients (5, 6). 
Acinetobacter baumannii is among leading clinically 
significant multi-drug resistant opportunistic nosocomial 
pathogens (5, 7). It is ubiquitous and can colonise medical 
devices as well as the skin and the airways of patients 
and hospital staff (8). Wide range of infections, long-
term survival, easy spread in the hospital environment 
and ability to rapidly acquire resistance determinants 
against most of antimicrobial agents are closely related 
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to intrinsic biological properties of A.baumannii 
(5). The ability of Acinetobacter spp. to exist in the 
environment of medical institutions,  attach  to  the 
surfaces of catheters, probes, respiratory tubes, contact 
lenses and form biofilms  indicates  their  leading role 
among  known  pathogens  of  infectious  complications 
associated  with the medical care. The presence in 
the biofilms gives pathogens additional resistance to 
antimicrobial agents and factors of the immune system, 
as well as new properties, which are not characteristic 
for planktonic forms of bacteria. Therefore, it is naturally 
that the acquisition of antibiotic resistance is increasing 
among high-biofilm forming strains of bacteria (2). 
As follows, it promotes increasing interest among 
scientists and practical physicians to overcoming 
outbreak of multi-drug resistant A.baumannii in ICU by 
monitoring of changes in its biological characteristics 
and implementation of new antibacterial drugs. 
The purpose of this research was to study the biofilm-
forming properties of clinical strains of A.baumannii, 
isolated from burn wounds in patients of ICU, and their 
sensitivity to antiseptics. 
MATERIALS AND METHODS
Biological samples had been collecting from 435 ICU 
infected burn patients in N. I. Pirogov Vinnitsa Regional 
Clinical Hospital during a 7-year period from 2011 to 
2018. Bacterial isolates were sampled from patients with 
second- and third-degree burns (burn area 30.0-85.0 
% of body surface) before antimicrobial medication. 
Patients with immunodeficiency, HIV, diabetes and 
other chronic diseases in history were excluded from 
the research. 
Samples included swabs from burn wounds, which 
were plated on 5% sheep blood agar and CHROMagar 
Acinetobacter (Paris, France). We incubated plates at 
37°C for 24 hours. Automatic bacteriological analyser 
Vitec - 2compact bioMérieux (France) carried out final 
identification. This study was approved by the ethics 
committee of National Pirogov Memorial Medical 
University and conformed to the provisions of the 
Declaration of Helsinki (as revised in Seoul, Republic of 
Korea, October 2008).
Cultivation and final biochemical identification of 
clinical bacterial strains were performed by the certified 
scientific bacteriological laboratory of the Department of 
Microbiology of the National Pirogov Memorial Medical 
University, Vinnytsya (certificate of the Ministry of 
Public Health of Ukraine No 049/15 from 02.02.2015). 
220 clinical strains of A. baumannii isolated from ICU 
infected burn patients were the object of the study.  
Antiseptic sensitivity of Acinetobacter spp. 
(decamethoxine, chlorhexidine, miramistin, 
povidone iodine) was investigated using double serial 
dilutions according to the standard procedure (9). 
The recommendations of European Committee on 
Antimicrobial Susceptibility Testing (EUCAST Expert 
rules) were used for the analysis of the susceptibility of 
A.baumanii clinical strains to antiseptics (10). 
The study of biofilm-forming properties of clinical 
Acinetobacter isolates was performed using the 
spectrophotometric technique by G.D. Christensen (MtP 
microtitre plate test). Biofilms were reproduced in wells 
of a sterile, flat-bottom 96-well polystyrene tray (Corning, 
USA) and stained with 1% solution of crystalline violet. 
Properties of the microorganisms to form a biofilm were 
evaluated by the degree of dye absorption in optical 
density units (ODU) using a spectrophotometer (570 
nm). The ability of microorganisms to form biofilms was 
assessed as low (at ODU <0.120), average (at ODU = 
0.121-0.239) and high (at ODU > 0.240) (14) (11, 12).
The statistical analysis of the results was carried out by 
standard “STATISTICA+” and “Microsoft Excel 2010” 
software packages. In order to determine the relationship 
between the antiseptic sensitivity and biofilm-forming 
properties of A. baumannii strains, we determined the 
correlation coefficient (r-Pearson), the absolute value of 
which characterised the binding force. 
RESULTS  
The findings obtained demonstrated the continuous high 
level of SSI among burn persons in ICU of N. I. Pirogov 
Vinnitsa Regional Clinical Hospital during a 7-year 
period from 2011 to 2018. SSI developed in 172±15 
patients of 1000 cases on average for 7 years. 
P. aureginosa (57.5±9.24 %), S. aureus (17.0±2.18 %), 
S. epidermidis (4.6±1.2 %), E. feacalis (3.9±1.9 %), 
E. faecium (2.3±1.42 %) were found as predominant 
pathogens, in burn patients, who were involved in the 
investigated group. The study showed representatives of 
Acinetobacter spp. were found in 220 (50.6%) among 
435 patients of ICU, that has revealed the etiological 
significance of the opportunistic pathogens of 
Acinetobacter isolates in the development of infectious 
complications of burns in ICU. 
Clinical strains of A. baumannii were the most susceptible 
to decamethoxine and the MBC (minimum bactericidal 
concentration) against them was 36.66±13.02 μg/
ml (Table I). Miramistin showed lower activity against 
investigated isolates in comparison to decamethoxine, 
but results had no statistical significance (p>0.05). 
Nevertheless, the MBC of chlorhexidine and povidone 
iodine were comparatively higher than the MBC of 
decamethoxine 1.9 and 99.7 times respectively. 
Acinetobacter strains, infecting burn wounds of ICU 
patients, have been found to possess high biofilm-
forming properties. The optical density of the biofilms 
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formed by these microorganisms were 0.45 ± 0.13 
ODU. 
The r-Pearson coefficient (+0.67) between sensitivity of 
A. baumannii to decamethoxine and biofilm-formation 
pointed out a positive moderate correlation (Fig. 1). That 
is, with the increase sensitivity of the microorganisms, 
their ability to form biofilms increases.
Nevertheless, relationship between sensitivity of clinical 
strains to miramistin and their biofilm-forming properties 
tends to the previous results with decamethoxine. The 
correlation value was r=+0.63 in this case, that proved 
a positive moderate correlation between investigated 
properties (Fig.2). 
The correlation coefficient between sensitivity of 
Acinetobacter strains to Povidone iodine and their 
biofilm formation was a little bit higher (+0.82), than 
r-Pirson coefficients with decamethoxine and miramistin. 
Its value pointed out a positive strong correlation (Fig.3). 
Ultimately, the r-Pearson coefficient (+0.9) between 
sensitivity of Acinetobacter strains to chlorhexidine 
and their biofilm formation has proved perfect strong 
positive correlation (Fig.4). 
 
DISCUSSION
Our study was focused on some of the most commonly 
used antiseptics in ICU patients: chlorhexidine, 
povidone iodine, miramistin and decamethoxine. The 
0.5% chlorhexidine digluconate is a “gold standard” in 
surgery. It is recommended in infected wounds, common 
skin infections as antiseptic agent. Chlorhexidine is used 
in healthy skin before and during minor surgeries (13). 
According to our results, chlorhexidine has shown lower 
effectiveness against Acinetobacter strains compared to 
other investigated antiseptics. It agrees with literature data 
about a steady increase in resistance to chlorhexidine 
among gram-negative pathogens (14, 15). It is due to a 
high frequency of qac genes in Acinetobacter baumannii, 
which promotes markedly reducing of its susceptibility 
to this antiseptic (15).  In turn, biofilm-forming properties 
of investigated clinical strains demonstrate the highest 
(perfect) positive correlation with their susceptibility rate 
to chlorhexidine. It provides ease of use and prognosis 
in combating SSI.
The povidone iodine consists of iodine and 
polyvinylpyrrolidone. It is commonly applied on healthy 
Figure 1: Correlation between sensitivity to decamethoxine 
and biofilm formation of A. baumannii (n = 220)
Table I: Susceptibility of A. baumannii (n=220) to antiseptics, M+m
Antiseptic MIC (μg/ml) MBC (μg/ml)
Decamethoxine 0,1% 20,87±7,73 36,66±13,02
Chlorhexidine 0,05% 45,07±23,28 69,41±36,42*
Miramistin 0,01% 41,35±11,95 57,21±17,65
Povidone iodine 10% 2271,64±1465,26 3653,85±2768,87*
Note: MIC - minimal inhibiting concentration; MBC - minimum bactericidal concentration; * 
- reliability of results differences of the MBC of chlorhexidine, povidone iodine comparatively 
to the MBC of decamethoxine, p<0.05.
Figure 2 Correlation between sensitivity to miramistin and 
biofilm formation of A. baumannii (n = 220)
Figure 3: Correlation between sensitivity to povidone iodine 
and biofilm formation of A. baumannii (n = 220)
Figure 4: Correlation between sensitivity to chlorhexidine 
and biofilm formation of A. baumannii (n = 220)
and contaminated skin before surgery, preoperative 
shower in its purest form. For the scrubbing of wounds, 
it is used in diluted form (13). The povidone iodine has 
demonstrated week effectiveness against Acinetobacter 
spp., however susceptibility to it shows very strong 
correlation with ability to form biofilm. In spite of 
frequent use of the povidone iodine in ICU worldwide, 
high MIC against SSI pathogens and individual iodine 
hypersensitivity would diminish its importance.
miramistin is a member of the cationic surface-active 
detergents. Although it has been known as an effective 
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antiseptic for the local treatment of infected wounds 
with low side effects since 1993, it is only used in 
Eastern Europe (16, 17). In our study, miramistin has 
shown high antimicrobial activity against Acinetobacter 
strains. Moreover, our results prove positive strong 
correlation between biofilm formation of A. baumannii 
and its susceptibility to miramistin. Nevertheless, it is a 
known fact, that miramistin shows significant cytotoxic 
effects in vitro (16). 
Decamethoxine is another member of the cationic 
surface-active detergents. Its antibacterial, antifungal, 
antiviral activities were proved by many-year studies 
and clinical trials (18, 19). Decamethoxine poins out the 
most powerful bactericidal effect on Acinetobacter spp. 
Additionally, susceptibility of investigated isolates to it 
are strongly correlated with biofilm-forming potential of 
A. baumannii. It obviously makes decamethoxine more 
predicted for use in treatment of SSI.
Results obtained during investigation have demonstrated 
strong correlation between biofilm-forming properties 
of Acinetobacter spp. with susceptibility to antiseptics, 
which antibacterial activity was much lower. It means 
that all isolates with high ability to form biofilms were 
less sensitive to povidone iodine and chlorhexidine. 
In turn, moderate correlation between susceptibility of 
A. baumannii to decamethoxine and miramistin and 
biofilm-formation of these microorganisms has proved 
that some clinical strains with high ability to form 
biofilms maintain sensitivity to mentioned antiseptics.
 
CONCLUSION
Decamethoxine, miramistin and chlorhexidine showed 
high antimicrobial activity against A. baumannii at low 
concentrations.  Biofilm-formation of Acinetobacter spp. 
is correlated with their susceptibility to chlorhexidine, 
povidone iodine, miramistin and decamethoxine 
perfectly and strongly. However, as more powerful 
antimicrobial activity of antiseptic against A. baumannii 
was as weaker correlation had been established.   
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